金城医药：10月23日召开董事会会议

Group 1 - Jincheng Pharmaceutical (SZ 300233) announced on October 26 that its 17th meeting of the 6th board of directors was held on October 23, 2025, to review proposals including the revision and establishment of certain corporate governance systems [1] - For the year 2024, Jincheng Pharmaceutical's revenue composition is 100% from the pharmaceutical manufacturing industry [1] - As of the report date, Jincheng Pharmaceutical has a market capitalization of 6.6 billion yuan [1]